ProCE Banner Activity

A European Perspective on the Key Studies in Multiple Myeloma Presented at ASH 2019

Clinical Thought
In this commentary, Jesús F. San-Miguel, MD, PhD, provides his perspective on key studies from ASH 2019.

Released: January 28, 2020

Expiration: January 26, 2021

Share

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Gilead

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Jesús F. San-Miguel, MD, PhD, has disclosed that he has received consulting fees from Amgen, Bristol-Myers Squibb, Celgene, Janssen, MSD, Novartis, Roche, Sanofi, and Takeda.